Cargando…
Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning
In a short time, the COVID-19 pandemic has left the world with over 25 million cases and staggering death tolls that are still rising. Treatments for SARS-CoV-2 infection are desperately needed as there are currently no approved drug therapies. With limited knowledge of viral mechanisms, a network c...
Autores principales: | Ackerman, Emily E., Shoemaker, Jason E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650805/ https://www.ncbi.nlm.nih.gov/pubmed/32993136 http://dx.doi.org/10.3390/v12101087 |
Ejemplares similares
-
Polypharmacology guided drug repositioning approach for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2023) -
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
por: Fan, Shiyong, et al.
Publicado: (2020) -
Recent computational drug repositioning strategies against SARS-CoV-2
por: Lu, Lu, et al.
Publicado: (2022) -
The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases
por: Gnilopyat, Sergey, et al.
Publicado: (2022) -
Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)